ChemicalBook >> CAS DataBase List >>GLPG-0778
GLPG-0778
- CAS No.
- 1206163-45-2
- Chemical Name:
- GLPG-0778
- Synonyms
- CS-2178;G 154578;GLPG-0778;Solcitinib;GSK 2586184;GSK 2586184A;GLPG 0778;GLPG-0778;Solcitinib(GLPG0778);GLPG0778, GSK2586184;Solcitinib (GSK2586184)
- CBNumber:
- CB12725627
- Molecular Formula:
- C22H23N5O2
- Molecular Weight:
- 389.45
- MDL Number:
- MFCD26960569
- MOL File:
- 1206163-45-2.mol
- MSDS File:
- SDS
Last updated:2023-06-08 09:03:09
Density | 1.40±0.1 g/cm3(Predicted) |
---|---|
storage temp. | Store at -20°C |
solubility | DMF: 2 mg/ml; DMSO: 5 mg/ml; Ethanol: 1 mg/ml |
form | A crystalline solid |
pka | 7.99±0.20(Predicted) |
FDA UNII | 3V7GQ1260K |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302 | |||||||||
Precautionary statements | P264-P270-P301+P312-P330-P501 | |||||||||
NFPA 704 |
|
GLPG-0778 price More Price(17)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 23439 | Solcitinib ≥98% | 1206163-45-2 | 1mg | $37 | 2024-03-01 | Buy |
Cayman Chemical | 23439 | Solcitinib ≥98% | 1206163-45-2 | 5mg | $161 | 2024-03-01 | Buy |
Cayman Chemical | 23439 | Solcitinib ≥98% | 1206163-45-2 | 10mg | $283 | 2024-03-01 | Buy |
Cayman Chemical | 23439 | Solcitinib ≥98% | 1206163-45-2 | 25mg | $618 | 2024-03-01 | Buy |
ChemScene | CS-5204 | Solcitinib 99.59% | 1206163-45-2 | 100mg | $450 | 2021-12-16 | Buy |
GLPG-0778 Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 69)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32686 | 60 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6393 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 | trendseenbio@gmail.com | China | 11681 | 58 |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | Mandy@hangyubiotech.com | China | 11013 | 58 |
Aladdin Scientific | +1-833-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323967 +86-18015559028 | sales1@artkmedchem.com | China | 39009 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131981 | 58 |
Shanghai Boyle Chemical Co., Ltd. | sales@boylechem.com | China | 2923 | 55 |
GLPG-0778
Solcitinib
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
Solcitinib (GSK2586184)
G 154578
GSK 2586184
GSK 2586184A
Solcitinib(GLPG0778)
Cyclopropanecarboxamide, N-[5-[4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-
GLPG0778, GSK2586184
GLPG 0778;GSK 2586184;GLPG-0778;GSK-2586184
Solcitinib - GSK 2586184 | GLPG 0778
GLPG 0778;GLPG-0778
CS-2178
Solcitinib(GLPG0778,GSK2586184)
GSK 2586184,GLPG 0778,Janus kinase,Inhibitor,Solcitinib,inhibit,GSK2586184,JAK,GLPG0778
1206163-45-2
API